176 related articles for article (PubMed ID: 9366523)
1. The chimeric oncoproteins E2A-PBX1 and E2A-HLF are concentrated within spherical nuclear domains.
LeBrun DP; Matthews BP; Feldman BJ; Cleary ML
Oncogene; 1997 Oct; 15(17):2059-67. PubMed ID: 9366523
[TBL] [Abstract][Full Text] [Related]
2. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
3. Critical role for a single leucine residue in leukemia induction by E2A-PBX1.
Bayly R; Murase T; Hyndman BD; Savage R; Nurmohamed S; Munro K; Casselman R; Smith SP; LeBrun DP
Mol Cell Biol; 2006 Sep; 26(17):6442-52. PubMed ID: 16914730
[TBL] [Abstract][Full Text] [Related]
4. The highest affinity DNA element bound by Pbx complexes in t(1;19) leukemic cells fails to mediate cooperative DNA-binding or cooperative transactivation by E2a-Pbx1 and class I Hox proteins - evidence for selective targetting of E2a-Pbx1 to a subset of Pbx-recognition elements.
Knoepfler PS; Kamps MP
Oncogene; 1997 May; 14(21):2521-31. PubMed ID: 9191052
[TBL] [Abstract][Full Text] [Related]
5. Chimeric oncoprotein E2a-Pbx1 induces apoptosis of hematopoietic cells by a p53-independent mechanism that is suppressed by Bcl-2.
Smith KS; Jacobs Y; Chang CP; Cleary ML
Oncogene; 1997 Jun; 14(24):2917-26. PubMed ID: 9205098
[TBL] [Abstract][Full Text] [Related]
6. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain--demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo.
Lu Q; Kamps MP
Oncogene; 1997 Jan; 14(1):75-83. PubMed ID: 9010234
[TBL] [Abstract][Full Text] [Related]
7. Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias.
LeBrun DP; Cleary ML
Oncogene; 1994 Jun; 9(6):1641-7. PubMed ID: 8183558
[TBL] [Abstract][Full Text] [Related]
8. Evidence for Hox and E2A-PBX1 collaboration in mouse T-cell leukemia.
Bijl J; Krosl J; Lebert-Ghali CE; Vacher J; Mayotte N; Sauvageau G
Oncogene; 2008 Oct; 27(49):6356-64. PubMed ID: 18679416
[TBL] [Abstract][Full Text] [Related]
9. DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation.
Kamps MP; Wright DD; Lu Q
Oncogene; 1996 Jan; 12(1):19-30. PubMed ID: 8552391
[TBL] [Abstract][Full Text] [Related]
10. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1.
Fu X; McGrath S; Pasillas M; Nakazawa S; Kamps MP
Oncogene; 1999 Sep; 18(35):4920-9. PubMed ID: 10490826
[TBL] [Abstract][Full Text] [Related]
11. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression.
Baudis M; Prima V; Tung YH; Hunger SP
Pediatr Blood Cancer; 2006 Nov; 47(6):757-64. PubMed ID: 16206189
[TBL] [Abstract][Full Text] [Related]
13. Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia.
Yamasaki N; Miyazaki K; Nagamachi A; Koller R; Oda H; Miyazaki M; Sasaki T; Honda ZI; Wolff L; Inaba T; Honda H
Oncogene; 2010 Apr; 29(13):1963-75. PubMed ID: 20062079
[TBL] [Abstract][Full Text] [Related]
14. E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells.
Yeung J; O'Sullivan E; Hubank M; Brady HJ
Br J Haematol; 2004 Jun; 125(5):560-7. PubMed ID: 15147370
[TBL] [Abstract][Full Text] [Related]
15. beta-catenin is involved in N-cadherin-dependent adhesion, but not in canonical Wnt signaling in E2A-PBX1-positive B acute lymphoblastic leukemia cells.
Nygren MK; Døsen-Dahl G; Stubberud H; Wälchli S; Munthe E; Rian E
Exp Hematol; 2009 Feb; 37(2):225-33. PubMed ID: 19101069
[TBL] [Abstract][Full Text] [Related]
16. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
Bourette RP; Grasset MF; Mouchiroud G
Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
[TBL] [Abstract][Full Text] [Related]
17. Oncoprotein E2A-Pbx1 immortalizes a myeloid progenitor in primary marrow cultures without abrogating its factor-dependence.
Kamps MP; Wright DD
Oncogene; 1994 Nov; 9(11):3159-66. PubMed ID: 7936638
[TBL] [Abstract][Full Text] [Related]
18. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable.
Monica K; LeBrun DP; Dedera DA; Brown R; Cleary ML
Mol Cell Biol; 1994 Dec; 14(12):8304-14. PubMed ID: 7969166
[TBL] [Abstract][Full Text] [Related]
19. Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1.
Knoepfler PS; Calvo KR; Chen H; Antonarakis SE; Kamps MP
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14553-8. PubMed ID: 9405651
[TBL] [Abstract][Full Text] [Related]
20. High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.
Bijl J; Sauvageau M; Thompson A; Sauvageau G
Genes Dev; 2005 Jan; 19(2):224-33. PubMed ID: 15655112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]